Psychedelic Decrim Has A Voter Problem. Nobody Wants To Talk About It.

Voter support for psychedelic research, therapy and prescription access all surged. Decrim didn’t move. A new Berkeley survey says it out loud.

Decriminalization is the line that didn’t move.

Two years of polling. Every other major psychedelic policy idea tracked by the UC Berkeley Center for the Science of Psychedelics gained ground with American voters. Support for making psychedelic research easier jumped 14 points. Backing for prescription-medicine access climbed 12. Therapeutic-use legalization rose 10. The numbers point at the doctor’s office.

Removing criminal penalties for personal possession? Twenty-nine percent in 2023. Twenty-eight percent in 2025. Nonsignificant.

Read that again. The decrim wing has been pushing the same argument for two years, and the public has not moved an inch.

That’s the takeaway in A Rising Tide of Cautious Support, the second annual UC Berkeley Psychedelics Survey, released this month. The headline numbers tell a story of momentum. The breakdown tells a different one. The psychedelic movement is winning on medical terms and losing on liberation terms. The gap is widening fast.

The Numbers That Moved, And The One That Didn’t

BCSP surveyed 1,577 registered voters between April 16 and 28, 2025. FM3 Research handled sampling and weighting. Margin of error: plus or minus 2.5 points.

Worth flagging upfront: the survey was funded by two anonymous donors. Doesn’t disqualify anything, but it’s the detail skeptics will hammer if it isn’t named.

The advocacy ecosystem has spent the past two years pushing on every front. Local decriminalization measures have multiplied. State legislatures have considered psychedelic bills in roughly half the country. A federal executive order earlier this year focused on expanding research into psychedelic-based mental health treatments. The activity is real. The polling number didn’t notice.

Medicine Sells. Liberation Doesn’t.

The clearest illustration of the split shows up when voters are asked who, specifically, should have access.

Given a choice between full prohibition, regulated therapeutic access or decriminalization for different populations, voters extended majority support to people receiving end-of-life care, military veterans, people with depression and people with addiction. 86% of voters back either regulated therapeutic access or removal of criminal penalties for people in end-of-life care. The strongest single number in the report.

Adults over 21? Thirty-seven percent support regulated therapeutic access. Twenty-six percent back decriminalization for that group. Twenty-six percent still say it should be illegal.

Watch this. Veterans, the depressed, the addicted and the dying all get majority approval for regulated access. Adults who just want to use psychedelics get a quarter of the country wanting them in jail.

The message tracks across the data. Voters want psychedelics available to people they see as sick, hurting or running out of options. They are not signing off on the right to use psychedelics because you want to.

What The Movement Doesn’t Want To Hear

The cognitive liberty wing of the psychedelic movement has been the philosophical engine of the policy fight since the 1970s. Personal use. Bodily sovereignty. The right not to be told what you can put in your own consciousness. Decrim ballot measures in Denver, Oakland and beyond were powered by that argument before therapeutic frameworks took the stage.

Parts of that advocacy wing have, at times, viewed the medicalization track with suspicion. Pharmaceutical capture. Regulatory gatekeeping. A “psychedelic exceptionalism” that wins access for clinical uses while the broader drug war grinds on.

Two years of survey data suggest the public has chosen sides in that quiet civil war. Not the side the cognitive liberty wing built its identity on.

The clinical and therapeutic framing is pulling the public along. The cognitive liberty framing has not moved a single point.

The Stigma Underneath

The medical lane is winning, but only by so much. Beneath the policy numbers sits a layer of social stigma the press release didn’t lead with.

Asked which words describe people who use psychedelics “pretty” or “extremely” well, voters most often picked “open-minded” (48%) and “creative” (37%). Then the floor drops out. “Moral” and “smart” describe psychedelic users well to just 16-17% of voters. About a quarter still land on “addicts” (24%) and “irresponsible” (24%).

Voters are willing to grant the sick and the wounded some access. They are still not sure psychedelic users themselves are good people.

The picture sharpens by demographic. Conservative voters describe psychedelics as a “cause of crime” at twice the liberal rate (37% versus 17%). They also rate users as “addicts” or “irresponsible” at significantly higher levels. Black voters reported the largest jump in exposure to psychedelics of any demographic group, up 15 points since 2023, the biggest shift in the dataset. They also report significantly higher safety concerns: 50% say “addictive” describes psychedelics well, compared to 34% of non-Black voters.

Exposure is rising. Stigma isn’t dissolving in step.

The Constituency, And Who It Doesn’t Include

The psychedelic renaissance has a constituency. Veterans. People at the end of their lives. Patients who have run out of conventional options. The clinical class. The research class. Voters who want a regulated path for someone they see as deserving.

It doesn’t, yet, include the person who just wants the right to use psychedelics on a Saturday night. That constituency built the movement. The data say it is the one the public isn’t moving with.

But here’s where this lands.

The wave is real. It just isn’t breaking where the movement built its beach.

Now We’re Talking About It: The Methodology Questions, Answered

Updated May 25, 2026. This piece argued that voter support for decriminalization has flatlined while support for medical and research access has surged. After it was published, that argument drew pushback, some of it dismissive, some of it substantive. The substantive part came from people who work in survey research and policy, and it deserves a real answer. So here it is. We pulled the full Berkeley report, including its methodology appendix, and checked each objection against the source. Two things turned out to be true at once: the critics raised fair points, and the central finding holds up.

1. The wording of the decrim question

The strongest objection came from a critic with a background in survey research and questionnaire design. The point: in the survey’s policy question, decriminalization is the only item phrased around removing something (“Removing criminal penalties for personal use possession”), while the other items are phrased around enabling something (“Making it easier,” “Obtaining FDA approval,” “Allowing”). Inconsistent framing like that, the argument goes, can depress support for the odd item out, because asking people to “remove penalties” can read differently than asking them to “allow” a regulated use.

The wording critique is correct. The questionnaire confirms it: five of the six items use enabling language, and decrim is the lone “removing” item. That’s a real inconsistency, and it’s a fair thing to flag when comparing decrim against the other policies within the 2025 results.

But here’s what the report’s own methodology appendix reveals, and it cuts the other way for this article’s actual claim. Between 2023 and 2025, Berkeley changed the wording of three of the four policy items it tracks over time, the research, prescription and therapeutic items. The one item that was left word-for-word identical across both years was decriminalization. The report says so explicitly, and warns readers that the shifts on the other items may be “partially or fully attributable” to those wording changes.

In other words: the wording critique lands when you compare decrim against the other items in a single year. It does not undercut the year-over-year flatline this piece was built on. If anything, the wording changes Berkeley made to the other items are a reason to read those gains with a little more caution, a caveat this article should have noted from the start, and does now.

2. FM3’s track record

Critics also pointed out that FM3 Research, the firm that worked on the survey, has drawn scrutiny over its polling accuracy. Media Bias/Fact Check, citing Nate Silver’s Silver Bulletin ratings, assigns FM3 a C- for predictive polling, indicating below-average accuracy and, in MBFC’s words, “poor methodological performance” in forecasting elections. That’s real, and worth knowing.

But two things keep it in perspective. First, those grades measure how well a pollster forecasts election outcomes, a different task from measuring public attitudes on an issue. Second, the same MBFC profile lists “None to date” under failed fact checks, meaning the firm hasn’t been flagged for reporting something false, and per the Berkeley report, FM3 handled sampling and statistical weighting while the survey questions themselves were developed by the Berkeley researchers. None of that makes the C- irrelevant. It’s context worth weighing, not a disqualifier.

3. The anonymous funding

Finally, the survey was funded by two anonymous donors. We agree that’s worth knowing, which is why this article flagged it in its original version, before the criticism, in the line noting that the funding “doesn’t disqualify anything, but it’s the detail skeptics will hammer if it isn’t named.” The donors are disclosed in the report’s acknowledgments. Anonymous funding is a fair thing for readers to factor in. It is not, on its own, evidence that the data were shaped to a conclusion.

And the bigger objection: does polling even matter?

One more argument came up, a broader one: that polling misses the point, because decriminalization is already spreading at the local level regardless of what voters tell pollsters. Millions of Americans now live in places where personal possession has effectively been decriminalized, often through city-council actions or local measures rather than statewide votes. That’s true. But it doesn’t cut against this piece. It’s the argument. Local decrim is advancing through the work of committed activists and sympathetic officials, not through a surge in broad public support. A flat poll number alongside real on-the-ground change is exactly what a movement winning by organizing rather than by persuasion looks like.

Where this leaves the story

The objections sharpened the picture. They didn’t overturn it. The gains on the research, prescription and therapeutic items should be read with the wording caveat in mind. The decrim number, the one this piece is about, sits on the survey’s single most stable question, and it didn’t move. Berkeley and FM3 have not publicly addressed these specific methodological questions; if they do, we’ll update again.

The headline said nobody wants to talk about decrim’s voter problem. Turns out plenty of people want to talk about the poll. The number at the center of it is still standing.